Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Net Margin (2020 - 2022)

SELLAS Life Sciences (SLS) has disclosed Net Margin for 3 consecutive years, with 1673.5% as the latest value for Q1 2022.

  • On a quarterly basis, Net Margin fell 163134.0% to 1673.5% in Q1 2022 year-over-year; TTM through Dec 2022 was 4195.0%, a 392264.0% decrease, with the full-year FY2022 number at 4130.1%, down 385774.0% from a year prior.
  • Net Margin was 1673.5% for Q1 2022 at SELLAS Life Sciences, down from 242.79% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 42.16% in Q1 2021 to a low of 1673.5% in Q1 2022.
  • A 3-year average of 538.51% and a median of 219.18% in 2020 define the central range for Net Margin.
  • Biggest YoY gain for Net Margin was -163134bps in 2022; the steepest drop was -163134bps in 2022.
  • SELLAS Life Sciences' Net Margin stood at 195.58% in 2020, then dropped by -24bps to 242.79% in 2021, then tumbled by -589bps to 1673.5% in 2022.
  • Per Business Quant, the three most recent readings for SLS's Net Margin are 1673.5% (Q1 2022), 242.79% (Q2 2021), and 42.16% (Q1 2021).